Sumary of Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases:
- Two recently published studies available on the National Institutes of Health (NIH) website indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases.
- This study can be viewed on the NIH website here: https://www.
- gov/pmc/articles/PMC8233978/ We ran Epstein-Barr virus serological tests on COVID-19 patients at least 90 days after testing positive for SARS-CoV-2 infection, comparing EBV reactivation rates of those with long COVID symptoms to those who never experienced long COVID symptoms.
- We found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation.
- Gold, Lead Study Author, World Organization Another group of researchers, Chen et al.
- (2021), found EBV reactivation may also be associated with COVID-19 severity.
- Related StoriesThe Pathogens study found that nearly one-third of 185 people surveyed who had tested positive for COVID-19 ended up with long haul symptoms, even some who were initially asymptomatic.
- This percentage of long term sequelae after COVID-19 infection was similar to the percentage found in a separate study Sequelae in Adults at 6 Months After COVID-19 Infection published in JAMA Network Open.